KRMN

AI Memo

Karman

As of 2026-09-12/Confidence medium/Horizon 6‑12m

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-12 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

6‑12m

Key catalyst

Delivery against raised FY2026 outlook • 2026-12-31

Base target: $38 / p=45% prob

Biggest risk

The thesis depends on timely backlog conversion, production execution and integration discipline. Term-loan principal increased to $863.961 million, while management was still remediating a material weakness and expected operating-effectiveness testing to continue into early 2027 [#8-K-2026-08-28] [#PR-EARNINGS-2026-08-13].

Invalidation

Break below $27 or thesis failure.

What would change my mind?

Record revenue, 24.4% organic growth, $1.3 billion of backlog, nearly $500 million of bookings and higher FY2026 guidance support a constructive growth thesis. Successful capacity expansion and backlog conversion could sustain momentum into 2027 [#SEC-8K-2026-08-06].

Research note

Recommendation

—

Confidence

medium

As of

2026-09-12

Base target

$38

p=45%

Bull target

$44

p=30%

Bear target

$27

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Leverage and acquisition-integration checkpoint
Backlog conversion and capacity expansion
Record revenue, 24.4% organic growth, $1.3 billion of backlog, nearly $500 million of bookings and higher FY2026 guidance support a constructive growth thesis.

BearKey bullets

Backlog may convert more slowly than expected because of production ramps, customer-program timing or execution constraints.
Failure to achieve the raised FY2026 revenue or adjusted-EBITDA ranges could trigger a sharp expectations reset.
Internal-control remediation was not yet complete on the Q2 call, with operating-effectiveness testing expected to continue into early 2027 [#PR-EARNINGS-2026-08-13].

WatchKey bullets

Delivery against raised FY2026 outlook

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

6‑12m

Asset

Equity

Trigger

Base case: $38 (p=45%)

Target spread vs base: +16% / -29%

Scenario probabilities

Bull Target: $44 (p=30%)Base Target: $38 (p=45%)Bear Target: $27 (p=25%)

Commentary

Primary-source tone remains positive because Q2 produced record revenue, earnings, backlog and bookings alongside raised guidance [#SEC-8K-2026-08-06]. The deterministic prior is still positive, but expected returns have moderated from the prior baseline. Post-release price-reaction attribution, analyst revisions, options skew, short interest, employee sentiment and sufficient social coverage are unavailable; zero-valued sentiment fields therefore denote missing data rather than neutral readings. The $35.28 anchor and unverified analyst-target coverage favor cautious monitoring over an aggressive bullish rating.

As of 2026-09-12 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Leverage and acquisition-integration checkpoint
Backlog conversion and capacity expansion

Scenarios

Bull Target (Scenario probability)

$44 / p=30% prob

Base Target (Scenario probability)

$38 / p=45% prob

Bear Target (Scenario probability)

$27 / p=25% prob

Analysis 2026-09-12 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.65

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-12-31
Delivery against raised FY2026 outlook
Karman raised its 2026 outlook to $730-$745 million of revenue and $215-$222.5 million of adjusted EBITDA after reporting $182.1 million of Q2 revenue, $54.6 million of adjusted EBITDA and 24.4% organic growth. Achieving the revised ranges is the principal year-end operating checkpoint [#SEC-8K-2026-08-06].
Prob 75.00% • Move 9.00% • Priced-in 70.00%

Short-term Catalysts

Next few weeks

Leverage and acquisition-integration checkpoint
2026-11-15
The August credit amendment increased term-loan principal by $100 million to $863.961 million. The next reporting cycle should clarify the resulting leverage, interest burden and acquisition-integration implications; weak disclosure or slower deleveraging could pressure the valuation [#8-K-2026-08-28].
Prob 85% • Move -6% • Priced-in 55%

Long-term Catalysts

Months to a year

Backlog conversion and capacity expansion
2027-06-30
Record backlog of $1.3 billion and nearly $500 million of quarterly bookings provide forward demand visibility, while management expects production capability at the new 200,000-square-foot Salt Lake City factory before year-end 2026. Conversion timing, program execution and ramp efficiency will determine whether growth persists into 2027 [#SEC-8K-2026-08-06] [#PR-EARNINGS-2026-08-13].
Prob 70% • Move 15% • Priced-in 60%

Risks

Backlog may convert more slowly than expected because of production ramps, customer-program timing or execution constraints.
Failure to achieve the raised FY2026 revenue or adjusted-EBITDA ranges could trigger a sharp expectations reset.
Internal-control remediation was not yet complete on the Q2 call, with operating-effectiveness testing expected to continue into early 2027 [#PR-EARNINGS-2026-08-13].
The Walker acquisition adds European expansion potential but also integration and capital-allocation risk; the packet provides no quantified post-closing contribution.
The additional $100 million of term-loan principal increases leverage and reduces flexibility if integration or cash generation disappoints [#8-K-2026-08-28].

Peers

Symbol	Summary
AGX	Similar market capitalization and capital-goods classification, but the packet does not establish comparable defense, space, backlog or program economics; useful only as a loose valuation reference.
PH	Parker-Hannifin offers broader aerospace exposure and operating-scale context, but its substantially larger size and diversified portfolio limit direct comparability with Karman.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-12

Loading AI feed…

Symbol

Summary

AGX

Similar market capitalization and capital-goods classification, but the packet does not establish comparable defense, space, backlog or program economics; useful only as a loose valuation reference.

Parker-Hannifin offers broader aerospace exposure and operating-scale context, but its substantially larger size and diversified portfolio limit direct comparability with Karman.